Micha Breakstone

2 stories about Micha Breakstone
NeuroSense & NeuraLight  R&D Teams

NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI

28.07.22|CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
NeuraLight Team

NeuraLight launches from stealth, raises $5.5 million to digitize neurology

31.10.21|James Spiro
After selling Chorus.ai to ZoomInfo for $575 million, co-founder Micha Breakstone is on to his next challenge